Radiation Therapy in Recurrent Pleomorphic Adenoma of the Parotid

Overview

Journal Int J Radiat Oncol Biol Phys

Specialties Oncology
Radiology

Date 1989 Mar 1

PMID 2537808

Citations 3

Authors

A K Dawson

Affiliations

Soon will be listed here.

Abstract

Twenty-nine patients were treated by excision and post-operative irradiation following recurrence of pleomorphic adenoma (mixed tumor) of the parotid. Eighteen of 20 (90%) patients with a first recurrence were controlled comparing favorably with series employing surgery only. Radiation therapy has a role to play as a surgical adjuvant in the management of these tumors, in particular when surgical difficulties are encountered and for second or subsequent recurrences.

Citing Articles

Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma.

Nicholas S, Fu W, Liang A, DeLuna R, Vujaskovic L, Bishop J Adv Radiat Oncol. 2021; 6(3):100674.

PMID: 34195493 PMC: 8233456. DOI: 10.1016/j.adro.2021.100674.

The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review.

Mc Loughlin L, Gillanders S, Smith S, Young O Eur Arch Otorhinolaryngol. 2018; 276(2):283-295.

PMID: 30426229 DOI: 10.1007/s00405-018-5205-z.

Management of lateral neck masses in adults.

Gleeson M, Herbert A, Richards A BMJ. 2000; 320(7248):1521-4.

PMID: 10834900 PMC: 1118107. DOI: 10.1136/bmj.320.7248.1521.